Dr. Aaron Debon, R&D Group Leader Enzymatic Bioconjugation

Written By BuzzCube

Aaron completed his master’s degree in interdisciplinary sciences, followed by a PhD thesis on protein engineering at ETH Zürich. During his tenure at Novartis as a postdoc, he focused on enzymatic peptide modification and bioconjugation. At INOFEA, he contributes his expertise as an R&D group leader in bioconjugation to further advance INOFEA‘s vision of enzymatically produced bioconjugates.

BuzzCube https://buzzcube.io
Previous

Dr. Agnese Pisano, R&D Group Leader IVT
Next

Dr. Marie Ruch, Scientist